Abstract
P385 Development of an AAV-mediated Pentatricopeptide Repeat Protein (PPR) delivery system for treatment of myotonic dystrophy type 1 (DM1)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have